Robinson Chandler Insider Trades

Insider Trading History

Track insider trading activity for Robinson Chandler. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $11.2M 103,351 shares
Last Trade
Jun 30, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.19M 12,873 shares
$92.59
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $10.8M 99,267 shares
Last Trade
Jun 30, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$378k 4,084 shares
$92.59
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $10.2M 93,403 shares
Last Trade
Jun 30, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.19M 12,873 shares
$92.59
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $10M 92,450 shares
Last Trade
Mar 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$369k 6,732 shares
$54.79
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $9.83M 90,478 shares
Last Trade
Mar 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$108k 1,972 shares
$54.79
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $11.6M 106,276 shares
Last Trade
Mar 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$369k 6,732 shares
$54.79
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $9.32M 85,718 shares
Last Trade
Dec 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$167k 2,558 shares
$65.30
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $12.3M 113,008 shares
Last Trade
Dec 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$570k 8,724 shares
$65.30
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $9.59M 88,276 shares
Last Trade
Dec 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$570k 8,724 shares
$65.30
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $13.2M 121,732 shares
Last Trade
Dec 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 65,886 shares
$75.94
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $8.93M 82,198 shares
Last Trade
Sep 30, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$713k 8,726 shares
$81.67
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $8.65M 79,552 shares
Last Trade
Sep 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$216k 2,646 shares
$81.67
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $7.89M 72,599 shares
Last Trade
Sep 30, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$713k 8,726 shares
$81.67
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jul 14, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$735k 16,800 shares
$43.73
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $9.81M 90,272 shares
Last Trade
Jul 14, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$735k 16,800 shares
$43.73
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $7.99M 73,472 shares
Last Trade
Jul 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$672k 16,800 shares
$40.00
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $8.62M 79,337 shares
Last Trade
Jun 30, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$477k 13,344 shares
$35.78
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $8.84M 81,325 shares
Last Trade
Jun 30, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$477k 13,344 shares
$35.78
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $7.99M 73,472 shares
Last Trade
Jun 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$210k 5,865 shares
$35.78
$108.69
Monopar Therapeutics
Monopar Therapeutics MNPR
Chief Executive Officer
Holding Value $7.17M 65,993 shares
Last Trade
Mar 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$43.8k 1,204 shares
$36.41
$108.69

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up